Bipsync and Burgiss team up to provide best-in-class capabilities to private market investors 4-04-2023, 20:07

Elucidat Certified as Smartchoice® Preferred Provider by 1-03-2023, 22:20

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO) 19-02-2025, 04:30